康众医疗：2025年预亏500万元至900万元

Core Viewpoint - Kangzhong Medical (688607.SH) is expected to report a significant decline in net profit for the year 2025, with projections indicating a decrease of 22.65 million to 26.65 million yuan, representing a year-on-year decline of 128.32% to 150.98% [1] Financial Performance - The company anticipates a net profit attributable to shareholders of the parent company ranging from -9 million to -5 million yuan for 2025 [1] - The expected net profit after deducting non-recurring gains and losses is projected to decrease by 17.94 million to 23.94 million yuan, reflecting a year-on-year decline of 301.88% to 402.82% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses is forecasted to be between -18 million and -12 million yuan [1] Influencing Factors - The decline in profitability is attributed to the downturn in the macroeconomic environment and geopolitical conflicts, which have led to significant fluctuations in tariffs, adversely affecting product gross margins [1] - The introduction of new products and business lines is still in the market penetration phase, requiring substantial upfront research and market investment, which is exerting short-term pressure on profits [1]